Advertisement

Ads Placeholder
Loading...

Evotec SE

EVT.DEXETRA
Healthcare
Drug Manufacturers - Specialty & Generic
4.50
0.04(0.96%)
German Market opens in 0h 52m

Evotec SE (EVT.DE) Stock Forecast & Price Predictions

Get the latest Evotec SE (EVT.DE) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price€3.93
Change↓ €-0.57 (-12.67%)

Quarterly Forecast

Predicted Price€3.15
Change↓ €-1.35 (-30.00%)

Yearly Forecast

Predicted Price€1.88
Change↓ €-2.62 (-58.25%)

3 Years Forecast

Predicted Price€0.00
Change↓ €-4.50 (-100.00%)

5 Years Forecast

Predicted Price€0.00
Change↓ €-4.50 (-100.00%)

7 Years Forecast

Predicted Price€0.00
Change↓ €-4.50 (-100.00%)

Evotec SE Stock Forecast Summary

Evotec SE (EVT.DE) stock is currently priced at $4.50. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $3.93.

In the long term, EVT.DE shows a bearish trend. The 2027 forecast points to $1.88 (-58.25% change), while the 2031 forecast suggests $0.00 (-100.00% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.

Overall Sentiment

Bearish

Short-Term Outlook

Bearish

Long-Term Outlook

Bearish

This mix indicates that Evotec SE stock is expected to face downside risk over the coming years.

Investment Calculator

Estimate your potential returns on EVT.DE based on our AI price forecasts. Enter your investment amount and select a target date.

Based on your investment of 1,000.00 in Evotec SE and holding until April 3rd, 2027, you could make a potential 582.50 loss, reflecting a -58.2% ROI over the next 365 days.

$Shares Bought

222.2222

@ €4.50/share

~Forecast Price

€1.88

1-year AI forecast

$Est. Portfolio Value

€417.50

€582.50 loss

%ROI

-58.2%

return on investment

Evotec SE yearly Price Forecast Chart

Explore the yearly forecast chart for EVT.DE, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Evotec SE over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for EVT.DEForecasting details for EVT.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Evotec SE Stock Forecast 2026

The forecast for Evotec SE (EVT.DE) in 2026 suggests a price of $1.88, representing a -58.25% move from today’s price.

Average Target: $1.88

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Frequently Asked Questions